FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Zynex TensWave for Pain Cleared

FDA clears a Zynex 510(k) for its TensWave, a transcutaneous electrical nerve stimulation therapy for reducing chronic and acute pain.

latest-news-card-1
Medical Devices

Ventis Emergency Transport Ventilator Cleared

FDA clears a Ventis Medical 510(k) for the VM-2000, an emergency transport ventilator that allows medical personnel to provide respiratory support in ...

latest-news-card-1
Human Drugs

Otsuka Pharmaceutical FDA-483 Released

FDA releases the form FDA-483 with five observations from an inspection at the Otsuka Pharmaceutical second factory in Tokushima, Japan.

latest-news-card-1
Medical Devices

FDA Clears Embecta Disposable Insulin Patch Pump

FDA clears an Embecta 510(k) for its Disposable Patch Pump for Insulin Delivery, intended for use by adults who require insulin to manage diabetes.

latest-news-card-1
Federal Register

Roche Cobas Covid/Flu Test EUA Revoked

Federal Register notice: FDA revokes a 2020 emergency use authorization granted to Roche Molecular Systems for the cobas SARS-CoV2 & Influenza A/B nuc...

latest-news-card-1
Federal Register

Intervertebral Body Graft Devices are Class 2

Federal Register notice: FDA classifies intervertebral body graft containment devices into Class 2 (special controls).

latest-news-card-1
Human Drugs

Atlanta Doctors Research Didnt Follow Plan: FDA

FDA warns Atlanta, GA-based physician Julio Flamini about concerns related to investigations at his Clinical Integrative Research Center of Atlanta.

latest-news-card-1
Biologics

Company Illegally Marketing Stem Cells: FDA

FDA warns Coral Gables, FL-based Mother Stem Institute about illegally marketing stromal vascular fraction products derived from donor adipose tissue ...

latest-news-card-1
Human Drugs

PhRMA Wants Changes to Platform Tech Designation

PhRMA makes nine recommendations for changes to an FDA draft guidance on the platform technology designation program.

latest-news-card-1
Human Drugs

Correct Misleading AbbVie Study Description: Ali

Ali Pharmaceutical asks FDA to require AbbVie to stop saying it is using Alis Armour Thyroid in a clinical trial since it is using a biologic with a d...